BioStem Technologies Inc.
BSEM | NASDAQ
$1.12
-$0.17 (-13.18%)
At close: Oct 30, 2026, 4:00 PM ET
$1.38
+$0.26 (+23.21%)
Pre-market:
Nov 2, 2026, 4:15 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 47.48M | 301.83M | 16.69M | 6.88M | 4.34M | 2.52M |
Cost of Revenue | 3.26M | 13.75M | 1.26M | 881.75K | 1.47M | 1.27M |
Gross Profit | 44.22M | 288.08M | 15.42M | 5.99M | 2.87M | 1.25M |
Operating Income | -689.15K | 31.2M | -7.78M | -4.68M | -1.61M | -1.84M |
Interest Income | 413.85K | n/a | n/a | n/a | n/a | 3.93K |
Pretax Income | -389.65K | 30.61M | -8.48M | -7.23M | -1.41M | -2.37M |
Net Income | -6.58M | 31.88M | -8.48M | -7.19M | -1.45M | -2.39M |
Selling & General & Admin | 37.82M | 254.75M | 22.63M | 10.21M | 4.19M | 3.09M |
Research & Development | 7.09M | 1.91M | 342K | 224.78K | 119.65K | n/a |
Other Expenses | n/a | 221.3K | 229.01K | 243.42K | 164.26K | 1 |
Operating Expenses | 44.91M | 256.88M | 23.2M | 10.67M | 4.47M | 3.09M |
Interest Expense | n/a | 587.22K | 700.33K | 468.15K | 525.88K | 530.9K |
Selling & Marketing Expenses | n/a | 236.06M | 11.99M | 954.06K | n/a | n/a |
Cost & Expenses | 48.17M | 270.63M | 24.46M | 11.56M | 5.95M | 4.36M |
Income Tax Expense | 6.19M | -1.27M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 16.73M | 16.37M | 13.71M | 11.4M | 9.32M | 9.18M |
Shares Outstanding (Diluted) | 16.73M | 21.7M | 13.71M | 11.4M | 9.32M | 9.18M |
EPS (Basic) | -0.39 | 1.95 | -0.62 | -0.63 | -0.15 | -0.26 |
EPS (Diluted) | -0.39 | 1.47 | -0.62 | -0.63 | -0.15 | -0.26 |
EBITDA | -469.73K | 31.49M | -7.55M | -6.52M | -602K | -1.59M |
EBIT | -689.15K | 31.2M | -7.78M | -6.76M | -885.9K | -1.84M |
Depreciation & Amortization | 219.42K | 293.22K | 229.02K | 243.42K | 283.9K | 243.47K |
Add to Watchlist
Select watchlists to add or remove BSEM